Results 141 to 150 of about 6,234 (197)

Anti-capsule human monoclonal antibodies protect against hypervirulent and pandrug-resistant Klebsiella pneumoniae

open access: yes
Abstract The silent pandemic caused by antimicrobial resistance (AMR) requires innovative therapeutic approaches. Human monoclonal antibodies (mAbs), which are among the most transformative, safe and effective drugs in oncology and autoimmunity, are rarely used for infectious diseases and not yet used for AMR.
Anna Kabanova   +29 more
openaire   +1 more source

Clonal Dissemination of Pandrug-Resistant <i>Klebsiella pneumoniae</i> ST392KL27 in a Tertiary Care Hospital in Mexico. [PDF]

open access: yesInt J Mol Sci
Cortés-Ortíz IA   +10 more
europepmc   +1 more source

DeNIS collaboration: setting the future research agenda. [PDF]

open access: yes, 2017
Folgori, L   +4 more
core   +1 more source

Corrigendum: Isolation and Characterization of a Novel Myophage Abp9 Against Pandrug Resistant Acinetobacater baumannii. [PDF]

open access: yesFront Microbiol, 2020
Jiang L   +8 more
europepmc   +1 more source

50: DEVELOPMENT OF PHAGE COCKTAIL AGAINST PAN-DRUG RESISTANT CLINICAL ISOLATES OF KLEBSIELLA PNEUMONIAE

open access: yesJournal of Global Antimicrobial Resistance, 2022
B. Wahid   +6 more
doaj   +1 more source

Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach. [PDF]

open access: yesJAC Antimicrob Resist
Clemente T   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy